SCHEMBL6000782

SCHEMBL6000782

CC(C)Cc1ccc(CCNc2ccc(-c3csc(CN(CC(=O)O)Cc4ccc(Cl)cc4)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
POLB P06746 2/20 0.41
GCGR P47871 6/20 0.40
GIPR P48546 6/20 0.40
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
MAPT P10636 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
USP2 O75604 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000713 0.93 MEN1 (0.48) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000755 0.91 KMT2A (0.48) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000726 0.88 RAB9A (0.42) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000738 0.88 MEN1 (0.39) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000779 0.84 PTPN2 (0.41) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000786 0.84 MEN1 (0.50) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000585 0.84 RAB9A (0.42) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000914 0.82 MEN1 (0.44) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6001089 0.81 MEN1 (0.42) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6001063 0.81 MEN1 (0.48) NPC1RAB9AMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 NPC1 955/4885RAB9A 1393/4885MEN1 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.